Eifelhöhen-Klinik AG (F:EIF) — Market Cap & Net Worth
Market Cap & Net Worth: Eifelhöhen-Klinik AG (EIF)
Eifelhöhen-Klinik AG (F:EIF) has a market capitalization of $10.05 Million (€8.60 Million) as of August 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #27013 globally and #2319 in its home market, demonstrating a 0.96% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Eifelhöhen-Klinik AG's stock price €4.20 by its total outstanding shares 2808001 (2.81 Million). See EIF capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Eifelhöhen-Klinik AG Market Cap History: 2015 to 2026
Eifelhöhen-Klinik AG's market capitalization history from 2015 to 2026. Data shows growth from $11.70 Million to $13.79 Million (1.22% CAGR).
Eifelhöhen-Klinik AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Eifelhöhen-Klinik AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
Eifelhöhen-Klinik AG's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
58.36x
Eifelhöhen-Klinik AG's market cap is 58.36 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $11.70 Million | $47.27 Million | -$968.34K | 0.25x | N/A |
| 2016 | $17.68 Million | $47.78 Million | $4.51 Million | 0.37x | 3.92x |
| 2017 | $16.75 Million | $46.94 Million | -$114.40K | 0.36x | N/A |
| 2018 | $10.31 Million | $49.32 Million | -$1.11 Million | 0.21x | N/A |
| 2019 | $6.57 Million | $48.45 Million | -$773.32K | 0.14x | N/A |
| 2020 | $12.67 Million | $35.48 Million | -$1.42 Million | 0.36x | N/A |
| 2021 | $12.34 Million | $35.80 Million | -$4.40 Million | 0.34x | N/A |
| 2022 | $11.10 Million | $37.55 Million | -$1.89 Million | 0.30x | N/A |
| 2023 | $4.92 Million | $45.33 Million | $481.31K | 0.11x | 10.23x |
| 2024 | $4.92 Million | $48.76 Million | $84.38K | 0.10x | 58.36x |
Competitor Companies of EIF by Market Capitalization
Companies near Eifelhöhen-Klinik AG in the global market cap rankings as of August 4, 2026.
Key companies related to Eifelhöhen-Klinik AG by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #328 globally with a market cap of $80.16 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #908 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #996 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1367 globally with a market cap of $18.41 Billion USD ( RM73.34 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #328 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $406.61 |
| #908 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €44.77 |
| #996 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1367 | IHH Healthcare Bhd | KLSE:5225 | $18.41 Billion | RM8.30 |
Eifelhöhen-Klinik AG Historical Marketcap From 2015 to 2026
Between 2015 and today, Eifelhöhen-Klinik AG's market cap moved from $11.70 Million to $ 13.79 Million, with a yearly change of 1.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €13.79 Million | +60.31% |
| 2025 | €8.60 Million | +74.67% |
| 2024 | €4.92 Million | 0.00% |
| 2023 | €4.92 Million | -55.62% |
| 2022 | €11.10 Million | -10.11% |
| 2021 | €12.34 Million | -2.59% |
| 2020 | €12.67 Million | +93.00% |
| 2019 | €6.57 Million | -36.31% |
| 2018 | €10.31 Million | -38.46% |
| 2017 | €16.75 Million | -5.28% |
| 2016 | €17.68 Million | +51.16% |
| 2015 | €11.70 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Eifelhöhen-Klinik AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.05 Million USD |
| MoneyControl | $10.05 Million USD |
| MarketWatch | $10.05 Million USD |
| marketcap.company | $10.05 Million USD |
| Reuters | $10.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Eifelhöhen-Klinik AG
MedNation AG operates facilities for outpatient and inpatient orthopedics, geriatrics, and internal medicine in Germany. The company is also involved in specialist clinic for cardiological rehabilitation. In addition, it operates specialist clinic with indications for neurology and orthopedics, as well as medical care, nursing, and inpatient care facilities. The company was formerly known as Eife… Read more